Summary of demographic characteristics for the obese subgroup
| Patient characteristics . | Apixaban n = 42 . | Standard of care n = 40 . |
|---|---|---|
| Age, y | ||
| Mean (SD) | 8.9 (4.40) | 9.4 (4.59) |
| Median | 9.0 | 10.5 |
| Male, n (%) | 30 (71.4) | 24 (60.0) |
| Ethnicity, n (%) | ||
| Hispanic | 11 (26.2) | 13 (32.5) |
| Non-Hispanic | 31 (73.8) | 27 (67.8) |
| Race, n (%) | ||
| White | 31 (73.8) | 32 (80) |
| Black or African American | 4 (9.5) | 2 (5) |
| Asian | 5 (11.9) | 2 (5) |
| Other | 2 (4.8) | 4 (10) |
| Diagnosis, n (%) | ||
| ALL | ||
| B-cell precursor | 41 (97.6) | 38 (95.0) |
| T-cell | 33 (78.6) | 33 (82.5) |
| Other | 9 (19.0) | 5 (12.5) |
| B-cell precursor | 0 | 0 |
| T-cell | 1 (2.4) | 2 (5.0) |
| CNS status, n (%) | ||
| CNS 1 | 39 (92.9) | 38 (95.0) |
| CNS 2 | 3 (7.1) | 2 (5.0) |
| WBC count, n (%) | ||
| <50 × 103/μL | 41 (97.6) | 37 (92.5) |
| ≥50 × 103/μL | 0 | 1 (2.5) |
| Not reported | 1 (2.4) | 2 (5.0) |
| Patient characteristics . | Apixaban n = 42 . | Standard of care n = 40 . |
|---|---|---|
| Age, y | ||
| Mean (SD) | 8.9 (4.40) | 9.4 (4.59) |
| Median | 9.0 | 10.5 |
| Male, n (%) | 30 (71.4) | 24 (60.0) |
| Ethnicity, n (%) | ||
| Hispanic | 11 (26.2) | 13 (32.5) |
| Non-Hispanic | 31 (73.8) | 27 (67.8) |
| Race, n (%) | ||
| White | 31 (73.8) | 32 (80) |
| Black or African American | 4 (9.5) | 2 (5) |
| Asian | 5 (11.9) | 2 (5) |
| Other | 2 (4.8) | 4 (10) |
| Diagnosis, n (%) | ||
| ALL | ||
| B-cell precursor | 41 (97.6) | 38 (95.0) |
| T-cell | 33 (78.6) | 33 (82.5) |
| Other | 9 (19.0) | 5 (12.5) |
| B-cell precursor | 0 | 0 |
| T-cell | 1 (2.4) | 2 (5.0) |
| CNS status, n (%) | ||
| CNS 1 | 39 (92.9) | 38 (95.0) |
| CNS 2 | 3 (7.1) | 2 (5.0) |
| WBC count, n (%) | ||
| <50 × 103/μL | 41 (97.6) | 37 (92.5) |
| ≥50 × 103/μL | 0 | 1 (2.5) |
| Not reported | 1 (2.4) | 2 (5.0) |
CNS, central nervous system; WBC, white blood cell.